Dark Light
-33%

Opzelura Ruxolitinib Cream For Vitiligo


Opzelura (ruxolitinib) Cream 1.5% is a prescription topical medicine indicated for the treatment of nonsegmental vitiligo in adults and children aged 12 years and older.

 999  1,499

Opzelura Ruxolitinib Cream For Vitiligo In Pakistan

Opzelura (ruxolitinib) Cream 1.5% is a topical prescription medicine containing ruxolitinib, a Janus kinase (JAK) inhibitor. It is indicated for the topical treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older.

Key Features

  • Contains ruxolitinib 1.5%
  • Topical cream formulation
  • Prescription medicine
  • Indicated for nonsegmental vitiligo
  • Approved for eligible adults and children aged 12+
  • Supplied in 60 g and 100 g tubes according to the U.S. prescribing information

How Opzelura Is Used for Vitiligo

The current prescribing information recommends applying a thin layer twice daily to affected areas covering up to 10% of body surface area. Treatment should be used according to a healthcare professional’s instructions.

Important Safety Information

Opzelura is for topical skin use only and should not be used in the eyes, mouth, or vagina. The prescribing information contains important warnings concerning serious infections, malignancy, major cardiovascular events, thrombosis and blood-count abnormalities.

Because Opzelura is a prescription medicine, consult a qualified healthcare professional before starting or changing treatment.

Note: Product availability, prescription requirements and regulatory status can vary by country.

Category:

Opzelura (ruxolitinib) Cream 1.5% is a prescription topical medicine indicated for the treatment of nonsegmental vitiligo in adults and children aged 12 years and older.

Based on 0 reviews

0.0 overall
0
0
0
0
0

Only logged in customers who have purchased this product may leave a review.

There are no reviews yet.